List of works - T. Scott Stroup

A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial

scientific article published on January 2010

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

scientific article

A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)

scientific article published on 18 July 2011

AKT1 and neurocognition in schizophrenia.

scientific article

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial

scientific article published in June 2011

Assessment of Medicaid managed behavioral health care for persons with serious mental illness.

scientific article published in October 2005

Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).

scientific article

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

scientific article published on 19 April 2006

Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial.

scientific article published in August 2009

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

scientific article

Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.

scientific article

Clozapine for Schizophrenia: State Variation in Evidence-Based Practice.

scientific article published on 2 November 2015

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

scientific article published on 15 May 2011

Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia

scientific article published on 6 November 2015

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

scientific article

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

scientific article

Correlates of family burden under medicaid managed mental health care.

scientific article published in November 2001

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

scientific article published on 01 December 2006

Criminal Justice System Involvement Among People with Schizophrenia ⬇️

scientific article published on November 28, 2010

Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.

scientific article published on 22 September 2005

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

scientific article published in July 2007

Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial

scientific article

Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.

scientific article

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

scientific article

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

scientific article

Effectiveness of long-acting injectable antipsychotics: a clinical perspective

scientific article published on 08 April 2015

Effectiveness of switching antipsychotic medications

scientific article published on 01 December 2006

Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

scientific article

Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.

scientific article

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

scientific article published in March 2007

Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs

scientific article published on 01 July 2006

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial ⬇️

scientific article published on February 21, 2013

Electronic health records in mental health research: a framework for developing valid research methods.

scientific article published on 17 November 2014

Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.

scientific article

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

scientific article

Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study.

scientific article

Factors associated with initiation on clozapine and on other antipsychotics among Medicaid enrollees.

scientific article

Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.

scientific article published on 15 May 2012

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

scientific article

Genome-wide association study of antipsychotic-induced QTc interval prolongation ⬇️

scientific article published on October 5, 2010

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

scientific article

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

scientific article

Genomewide association for schizophrenia in the CATIE study: results of stage 1

scientific article (publication date: June 2008)

Genomewide association study of movement-related adverse antipsychotic effects

scientific article

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

scientific article

Geographic and clinical variation in clozapine use in the United States.

scientific article published on February 2014

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

scientific article published on 04 June 2008

Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

scientific article published on 29 July 2009

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

scientific article

Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

scientific article

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

scientific article published on 8 April 2022

Medications for first-episode psychosis: making a good start.

scientific article published in March 2015

Microduplications of 16p11.2 are associated with schizophrenia

scientific article

NCAM1 and neurocognition in schizophrenia

scientific article published on 08 December 2006

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

scientific article

No association of the serotonin transporter polymorphisms 5-HTTLPR and RS25531 with schizophrenia or neurocognition.

scientific article

No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

scientific article published on 01 February 2011

Oral paliperidone for schizophrenia

scientific article

Polypharmacy for schizophrenia.

scientific article

Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

scientific article published on 05 January 2011

Pragmatic design in randomized controlled trials.

scientific article published on 2 June 2014

Premature Mortality Among Adults With Schizophrenia in the United States.

scientific article published on 28 October 2015

Public-academic partnerships: a rapid small-grant program for policy-relevant research: motivating public-academic partnerships.

scientific article published on February 2013

Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia

scientific article

Response to Rosenfeld

scientific article published on 01 January 2014

Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparators.

scientific article published on August 2006

Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia ⬇️

scientific article published on May 1, 2010

Risperidone versus olanzapine for treatment of schizophrenia.

scientific article

Schizophrenia genetic variants are not associated with intelligence

scientific article published on 15 February 2013

Schizophrenia, drug therapy, and monitoring

scientific article

Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial

scientific article published on 01 April 2007

Service use and health status of persons with severe mental illness in full-risk and no-risk medicaid programs.

scientific article

Sexually dimorphic aging of dendritic morphology in CA1 of hippocampus.

scientific article published in January 2005

Substance use and schizophrenia: Adverse correlates in the CATIE study sample ⬇️

scientific article published on August 26, 2011

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

scientific article

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

scientific article published on 24 August 2005

The NIMH-CATIE Schizophrenia Study: what did we learn?

scientific article published on 01 August 2011

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia

article

The association between weight change and symptom reduction in the CATIE schizophrenia trial ⬇️

scientific article published on February 21, 2011

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

scientific article

The enduring challenge of antipsychotic non-adherence

scientific article published on October 2013

The need to determine the best options for people with schizophrenia that is unresponsive to treatment.

scientific article published on 19 July 2012

The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition.

scientific article published on October 2008

Tobacco use and mental illness: a wake-up call for psychiatrists

scientific article published on 31 October 2014

Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

scientific article published on 10 August 2010

What Can Large Simple Trials Do for Psychiatry? ⬇️

scientific article published on February 1, 2011

What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?

scientific article published on 01 November 2014

List of works by T. Scott Stroup

A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)

AKT1 and neurocognition in schizophrenia.

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial

Assessment of Medicaid managed behavioral health care for persons with serious mental illness.

Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial.

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.

Clozapine for Schizophrenia: State Variation in Evidence-Based Practice.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Correlates of family burden under medicaid managed mental health care.

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia

Criminal Justice System Involvement Among People with Schizophrenia ⬇️

Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial

Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Effectiveness of long-acting injectable antipsychotics: a clinical perspective

Effectiveness of switching antipsychotic medications

Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial ⬇️

Electronic health records in mental health research: a framework for developing valid research methods.

Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study.

Factors associated with initiation on clozapine and on other antipsychotics among Medicaid enrollees.

Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Genome-wide association study of antipsychotic-induced QTc interval prolongation ⬇️

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

Genomewide association for schizophrenia in the CATIE study: results of stage 1

Genomewide association study of movement-related adverse antipsychotic effects

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

Geographic and clinical variation in clozapine use in the United States.

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Medications for first-episode psychosis: making a good start.

Microduplications of 16p11.2 are associated with schizophrenia

NCAM1 and neurocognition in schizophrenia

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

No association of the serotonin transporter polymorphisms 5-HTTLPR and RS25531 with schizophrenia or neurocognition.

No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

Oral paliperidone for schizophrenia

Polypharmacy for schizophrenia.

Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

Pragmatic design in randomized controlled trials.

Premature Mortality Among Adults With Schizophrenia in the United States.

Public-academic partnerships: a rapid small-grant program for policy-relevant research: motivating public-academic partnerships.

Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia

Response to Rosenfeld

Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparators.

Review: ziprasidone is marginally less effective than other atypical antipsychotics in people with schizophrenia ⬇️

Risperidone versus olanzapine for treatment of schizophrenia.

Schizophrenia genetic variants are not associated with intelligence

Schizophrenia, drug therapy, and monitoring

Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial

Service use and health status of persons with severe mental illness in full-risk and no-risk medicaid programs.

Sexually dimorphic aging of dendritic morphology in CA1 of hippocampus.

Substance use and schizophrenia: Adverse correlates in the CATIE study sample ⬇️

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

The NIMH-CATIE Schizophrenia Study: what did we learn?

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia